1. Home
  2. CNM vs BIO Comparison

CNM vs BIO Comparison

Compare CNM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core & Main Inc.

CNM

Core & Main Inc.

HOLD

Current Price

$53.15

Market Cap

9.0B

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$302.51

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNM
BIO
Founded
1996
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CNM
BIO
Price
$53.15
$302.51
Analyst Decision
Buy
Strong Buy
Analyst Count
11
4
Target Price
$60.82
$358.50
AVG Volume (30 Days)
2.5M
152.0K
Earning Date
12-09-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
7.81
N/A
EPS
2.28
N/A
Revenue
$7,764,000,000.00
$2,557,500,000.00
Revenue This Year
$4.27
$1.62
Revenue Next Year
$4.07
$2.26
P/E Ratio
$22.83
N/A
Revenue Growth
8.09
N/A
52 Week Low
$43.18
$211.43
52 Week High
$67.18
$373.69

Technical Indicators

Market Signals
Indicator
CNM
BIO
Relative Strength Index (RSI) 52.91 45.34
Support Level $53.16 $300.26
Resistance Level $54.45 $305.62
Average True Range (ATR) 1.11 6.99
MACD -0.26 0.02
Stochastic Oscillator 22.45 44.89

Price Performance

Historical Comparison
CNM
BIO

About CNM Core & Main Inc.

Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: